;
Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Biocept sales and marketing update

    Biocept Inc. (NASDAQ:BIOC), San Diego, Calif. Business: Diagnostic Biocept launched its OncoCEE-LU blood-based biomarker test for non-small cell lung cancer (NSCLC). The test will be performed at Biocepts CLIA-…

    Published on 11/24/2014
  • Cubist, Omnicare sales and marketing update

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Omnicare Inc. (NYSE:OCR), Cincinnati, Ohio Business: Infectious Omnicares Advanced Care Scripts (ACS) division will provide an integrated pharmacy solution for…

    Published on 11/24/2014
  • Dr. Reddys Laboratories Ltd. sales and marketing update

    Dr. Reddys Laboratories Ltd. (NYSE:RDY), Hyderabad, India Business: Transplant Dr. Reddys launched sirolimus tablets for the prophylaxis of organ rejection in patients older than 13 years who have had renal transplants.…

    Published on 11/24/2014
  • Eisai sales and marketing update

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Neurology Eisai launched Fycompa perampanel in Australia to treat partial-onset seizures with or without secondarily generalized seizures in epileptics ages 12 years …

    Published on 11/24/2014
  • Genomica S.A.U., Scienion sales and marketing update

    Genomica S.A.U., Madrid, Spain Scienion AG, Berlin, Germany Business: Infectious The companies launched Clart STIs A&Beta, a detection kit for identifying and differentiating 18 different microorganisms that cause …

    Published on 11/24/2014
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic, Drug delivery Novo Nordisk launched NovoFine Plus in the U.S. to deliver insulin and some glucagon-like peptide-1 (GLP-1) receptor …

    Published on 11/24/2014
  • Octapharma sales and marketing update

    Octapharma AG, Lachen Switzerland Business: Hematology Octapharmas Octapharma USA subsidiary launched Octagam 10% human IV Ig in the U.S. for adults with chronic immune thrombocytopenic purpura (ITP). The packaging size…

    Published on 11/24/2014
  • Salix sales and marketing update

    Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), Raleigh, N.C. Business: Inflammation Salix launched Ruconest conestat alfa in the U.S. to treat acute angioedema attacks in patients with hereditary angioedema (HAE). The …

    Published on 11/24/2014
  • AOP Orphan sales and marketing update

    AOP Orphan Pharmaceuticals AG, Vienna, Austria Business: Hematology AOP Orphan launched Thromboreductin anagrelide in Russia to treat essential thrombocythemia. The product comes in 0.5 mg capsules.

    Published on 11/17/2014
  • Boehringer Ingelheim sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Pulmonary Boehringer launched Ofev nintedanib in the U.S. to treat idiopathic pulmonary fibrosis (IPF). Ofev has Orphan Drug and breakthrough therapy status in the…

    Published on 11/17/2014
  • Eli Lilly sales and marketing update

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Lilly launched Trulicity dulaglutide in the U.S. to help improve glycemic control in adults with Type 2 diabetes. The 0.75 and 1.5 mg …

    Published on 11/17/2014
  • Fluidigm sales and marketing update

    Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. Business: Microfluidics Fluidigm launched a new application for its C1 single-cell auto prep system called single-cell whole exome sequencing workflow. The new …

    Published on 11/17/2014
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic, Drug delivery Novo Nordisk launched the NovoRapid PumpCart in the U.K., Sweden and Austria. The company said the product, which is …

    Published on 11/17/2014
  • Quest Diagnostics sales and marketing update

    Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Business: Diagnostic Quest launched BRCAvantage Plus in the U.S. to screen for mutations in breast cancer 1 early onset (BRCA1), BRCA2, tumor protein p53 (TP53), …

    Published on 11/17/2014
  • Roche sales and marketing update

    Roche (SIX:ROG;OTCQX:RHHBY), Basel, Switzerland Business: Genomics Roche's NimbleGen Inc. unit launched the SeqCap RNA target enrichment system for RNA-Seq applications. The company said the system increases RNA-Seq's …

    Published on 11/17/2014
  • Vela Diagnostics sales and marketing update

    Vela Diagnostics, Singapore Business: Diagnostic Vela launched Sentosa SQ non-small cell lung cancer (NSCLC) and Sentosa colorectal cancer (CRC) panels available for research use. Both panels target 11 genes.

    Published on 11/17/2014
  • BioTime sales and marketing update

    BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Bioinformatics BioTime's LifeMap Sciences Inc. subsidiary launched MalaCards version 1.06. The company, which launched the original version in 2012, said the updated …

    Published on 11/10/2014
  • Fujifilm sales and marketing update

    Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan Business: Supply/Service Fujifilm's Diosynth Biotechnologies unit launched Apollo, a mammalian expression platform to create manufacturing-ready cell lines. Fujifilm …

    Published on 11/10/2014
  • Medac sales and marketing update

    Medac GmbH, Wedel, Germany Business: Autoimmune Medac launched Rasuvo methotrexate in the U.S. to treat rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (pJIA) and psoriasis. The autopen containing …

    Published on 11/10/2014
  • Purdue Pharma sales and marketing update

    Purdue Pharma L.P., Stamford, Conn. Business: Neurology Purdue launched 7.5 ug/hour Butrans buprenorphine transdermal system CIII in the U.S. to manage pain requiring around-the-clock opioid analgesic for an extended …

    Published on 11/10/2014
  • Roche sales and marketing update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer, Autoimmune Roche's Genentech Inc. unit announced that cancer drugs Avastin bevacizumab and Herceptin trastuzumab and cancer and autoimmune drug Rituxan …

    Published on 11/10/2014
  • Baxter sales and marketing update

    Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Hematology Baxter launched HyQvia Ig infusion 10% in the U.S. to treat adults with primary immunodeficiency. Baxter said HyQvia gives patients the option …

    Published on 11/3/2014
  • Boehringer Ingelheim sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Pulmonary Boehringer launched Striverdi Respimat olodaterol in the U.S. to treat airflow limitations in patients with chronic obstructive pulmonary disease (COPD).…

    Published on 10/27/2014
  • NextCode sales and marketing update

    NextCode Health, Cambridge, Mass. Business: Genomics NextCode launched its NextCode Exchange genomic data analysis and collaboration service. NextCode said the exchange will enable scientists and clinicians to …

    Published on 10/27/2014
  • Nicox sales and marketing update

    Nicox S.A. (Euronext:COX), Sophia Antipolis, France Business: Ophthalmic Nicox launched Xailin Gel in Europe to treat dry eye syndrome. The product is a multidose carbomer gel lubricant.

    Published on 10/27/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993